XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2022
Mar. 31, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Cash flows from operating activities:              
Net loss $ (681,030) $ (430,063) $ (480,288) $ (860,163) $ (1,111,093) $ (1,340,451)  
Adjustments to reconcile net loss to net cash used in operating activities:              
Amortization of original issue discount, capitalized note costs and debt discounts to interest expense         11,076 336,728  
Foreign currency transaction (gain) loss         (37,646) (68,145)  
Increase (decrease) in cash from              
Deferred financing costs         (6,661) 177,883  
Prepaid expenses         (104,601) 47,619  
Accounts payable and accrued expenses         205,970 304,382  
Accrued compensation and related expenses         360,600 360,100  
Officer and affiliate liabilities, including accrued interest         340,312    
Accrued interest payable and notes payable         184,276 96,762  
Net cash used in operating activities         (157,767) (85,122) $ (143,905)
Cash flows from financing activities:              
Proceeds from preferred stock financings         70,000  
Proceeds from convertible note financing         25,000  
Proceeds from demand promissory notes         95,000  
Payment of fees associated with conversions of convertible notes by issuance of stock         1,500  
Borrowings on or repayments of short-term notes payable         (37,752)  
Proceeds from or repayment of officer advance         94,997  
Net cash provided by financing activities         165,000 83,745  
Cash and cash equivalents:              
Net increase (decrease)         7,233 (1,377)  
Balance at beginning of period   $ 88   $ 1,398 88 1,398 1,398
Balance at end of period $ 7,321   $ 21   7,321 21 $ 88
Cash paid for -              
Interest         4,728 5,657  
Income taxes          
Non-cash financing activities:              
Amortization of deferred financing costs         11,075  
Insurance policies         96,470 95,850  
Reclassification of long-term liabilities to short-term liabilities         100,000 60,000  
Debt discounts established for convertible debt         25,000  
Accrued compensation, accounts payable and other liabilities exchanged or settled for equity         570,000  
Debt and accrued interest and related fees converted to common stock         84,060 190,250  
Cashless warrant exercises         $ 39,145